Immunological and biochemical markers in preeclampsia

Journal of Reproductive Immunology

Volumn 96, Issue 1-2, 2012, Pages 90-94

  Kestlerova A ^a,d   Feyereisl, J ^a   Frisova V ^b,c   Mechurova A ^a   Sula K ^a   Zima, T ^d   Belacek J ^d   Madar, J ^a  

^a INSTITUTE FOR THE CARE OF MOTHER AND CHILD   (Czech Republic)

^b Profema Fetal Medicine Centre Ltd   (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Anti cardiolipin autoantibodies; Cell mediated immunity; Immunoglobulins; Preeclampsia; Trophoblast

Indexed keywords

BIOCHEMICAL MARKER; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; BLOOD SAMPLING; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; EDEMA; FEMALE; HUMAN; MATERNAL HYPERTENSION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; TROPHOBLAST;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CARDIOLIPINS; COMPLEMENT C3; COMPLEMENT C4; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULINS; PRE-ECLAMPSIA; PREGNANCY; TROPHOBLASTS; YOUNG ADULT;

EID: 84872397550     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.10.002     Document Type: Article

References (23)

1. Blank M., Shoenfeld Y. Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome. Clin Rév Allerg Immunol 2010, 38:141-147.
2. Bonney E.A. Preeclampsia: a view through the danger model. J. Reprod. Immunol. 2007, 76:68-74.
3. Chaouat G., Ledee-Bataille N., Zourbas S., Dubanchet S., Sandra O., Martal J., Ostojojic S., Frydman R. Implantation: can immunological parameters of implantation failure be of interest for pre-eclampsia?. J. Reprod. Immunol. 2003, 59:205-217.
4. Chaouat G., Petitbarat M., Bulla R., Dubanchet S., Valdivia K., Ledée N., Steffen T., Jensenius J.C., Tedesco F. Early regulators in abortion and implications for a preeclampsia model. J. Reprod. Immunol. 2009, 82:132-141.
5. Clark E.A., Silver R.M., Branch D.W. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?. Curr. Rheumatol. Rep. 2007, 9:219-225.
6. Clausen E. Migration inhibitory effect of cell-free supernatants from tuberculin-stimulated cultures of human mononuclear leukocytes demonstrated by two-step MIF agarose assay. J. Immunol. Methods 1973, 110:546-550.
7. Conrad K.P., Benyo D.F. Placental cytokines and the pathogenesis of preeclampsia. Am. J. Obstet. Gynecol. 2006, 194:1213-1214.
8. Dimitrov D.G., Sedlák R., Nouza K., Kinsky R. A quantitative objective method for the evaluation of anti-sperm cell-mediated immunity in humans. J. Immunol. Methods 1992, 154:l47-l153.
9. Eastbrook G., Brown M., Sargent I. The origins and end-organ consequence of pre-eclampsia. Best Pract Res Clin Obst Gynaecol 2011, 1-13.
10. Fialová L., Kalousova M., Soukupová J., Malbohan I., Madar J., Frisová V., Štípek S., Zima T. Markers of inflammation in preeclampsia. Prague Med Rep 2004, 105:301-310.
11. Fialová L., Malbohan L, Kalousova M., Soukupová J., Krofta L., Štípek S., Zima T. Oxidative stress and inflammation in pregnancy. Scand. J. Clin. Lab. Invest. 2006, 66:121-127.
12. Hradecky L., Subrt I., Ulcova-Gallova Z. Urgent termination of pregnancy in pre-eclampsia and panel of antiphospholipid antibodies. Am. J. Reprod. Immunol. 2009, 62:412-417.
13. Irani R.A., Zhang Y., Zhou C.C., Blackwell S.C., Hicks M.J., Ramin S.M., Kellems R.E., Xia Y. Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension 2010, 55:1246-1253. (Epub 2010 Mar29).
14. James J.L., Whitley G.S., Cartwright J.E. Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J. Pathol. 2010, 221:363-378.
15. Madar J., Peknicova J., Sula K., Tolarová M., Novákova D., Kinsky R. Anti-trophoblast and anti-cardiolipin immunity in repeated miscarriages - diagnosis and treatment (Abstract). J. Reprod. Immunol. 2003, 58:179-180.
16. Redman W.G., Sargent I.L. Immunology of pre-eclampsia. Amer J Reprod Immunol 2010, 63:534-543.
17. Salmon J.E., Girardi G. The role of complement in the antiphospholipid syndrome. Curr. Dir. Autoimmun. 2004, 7:133-148.
18. Salmon J.E., Girardi G. Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. J. Reprod. Immunol. 2008, 77:51-56.
19. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
20. Springer D., Zima T., ArnoŠtova L. Stability of free beta-hCG in the routine screening of Down syndrome in the first trimester of pregnancy. Prague Med řep 2008, 109:134-141.
21. Thornton C.A., Holloway J.á., Shute J.K., Holloway D.W., Diaper N.D., Warner J.O. Human mid-gestation amniotic fluid contains interleukin-16 bioactivity. Immunology 2009, 126:543-551.
22. Tubbergen P., Lachmeijer A.M., Althuisius S.M., Vlak Mé, van Geijn H.P., Dekker G.A. Change in paternity: a risk factor for preeclampsia in multiparous women?. J. Reprod. Immunol. 1999, 45:81-88.
23. Xia Y., Kellems R.E. Is preeclampsia an autoimmune disease?. Clin. Immunol. 2009, 133:1-12.